{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T04:28:34Z","timestamp":1782534514606,"version":"3.54.5"},"reference-count":38,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1136\/thoraxjnl-2014-206067","type":"journal-article","created":{"date-parts":[[2015,3,7]],"date-time":"2015-03-07T03:13:17Z","timestamp":1425697997000},"page":"458-467","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":123,"title":["Macrolide therapy suppresses key features of experimental steroid-sensitive and steroid-insensitive asthma"],"prefix":"10.1136","volume":"70","author":[{"given":"Ama-Tawiah","family":"Essilfie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay C","family":"Horvat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard Y","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jemma R","family":"Mayall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W","family":"Pinkerton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma L","family":"Beckett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm R","family":"Starkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodie L","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M","family":"Hansbro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2015,3,6]]},"reference":[{"key":"key-10.1136\/thoraxjnl-2014-206067-1","first-page":"1198","article-title":"Difficult\/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult\/Therapy-Resistant Asthma. European Respiratory Society","volume":"13","author":"Chung","year":"1999","journal-title":"Eur Respir J"},{"key":"key-10.1136\/thoraxjnl-2014-206067-2","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2174\/138945010791591412","article-title":"Potential therapeutic targets for steroid-resistant asthma","volume":"11","author":"Wang","year":"2010","journal-title":"Curr Drug Targets"},{"key":"key-10.1136\/thoraxjnl-2014-206067-3","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1136\/thorax.57.10.875","article-title":"Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids","volume":"57","author":"Green","year":"2002","journal-title":"Thorax"},{"key":"key-10.1136\/thoraxjnl-2014-206067-4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1465-9921-7-135","article-title":"IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx?","volume":"7","author":"Bullens","year":"2006","journal-title":"Respir Res"},{"key":"key-10.1136\/thoraxjnl-2014-206067-5","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.4049\/jimmunol.181.6.4089","article-title":"Th17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice","volume":"181","author":"McKinley","year":"2008","journal-title":"J Immunol"},{"key":"key-10.1136\/thoraxjnl-2014-206067-6","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.4049\/jimmunol.0803468","article-title":"Pathogenesis of steroid-resistant airway hyperresponsiveness: Interaction between IFN-\u03b3 and TLR4\/MyD88 pathways","volume":"182","author":"Yang","year":"2009","journal-title":"J Immunol"},{"key":"key-10.1136\/thoraxjnl-2014-206067-7","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1128\/IAI.68.2.960-964.2000","article-title":"Acquired immunity to Chlamydia pneumoniae is dependent on gamma interferon in two mouse strains that initially differ in this respect after primary challenge","volume":"68","author":"Vuola","year":"2000","journal-title":"Infect Immun"},{"key":"key-10.1136\/thoraxjnl-2014-206067-8","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1128\/IAI.00403-09","article-title":"Critical role of the Interleukin-17\/Interleukin-17 receptor axis in regulating host susceptibility to respiratory infection with Chlamydia species","volume":"77","author":"Zhou","year":"2009","journal-title":"Infect Immun"},{"key":"key-10.1136\/thoraxjnl-2014-206067-9","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1183\/09031936.02.00192002","article-title":"Chlamydia pneumoniae immunoglobulin A reactivation and airway inflammation in acute asthma","volume":"20","author":"Wark","year":"2002","journal-title":"Eur Respir J"},{"key":"key-10.1136\/thoraxjnl-2014-206067-10","doi-asserted-by":"crossref","first-page":"e1002244","DOI":"10.1371\/journal.ppat.1002244","article-title":"Haemophilus influenzae infection drives IL-17-mediated neutrophilic allergic airways disease","volume":"7","author":"Essilfie","year":"2011","journal-title":"PLoS Pathog"},{"key":"key-10.1136\/thoraxjnl-2014-206067-11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.coph.2013.03.005","article-title":"Murine models of infectious exacerbations of airway inflammation","volume":"13","author":"Starkey","year":"2013","journal-title":"Curr Opin Pharmacol"},{"key":"key-10.1136\/thoraxjnl-2014-206067-12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/thx.2006.061358","article-title":"Innate immune activation in neutrophilic asthma and bronchiectasis","volume":"62","author":"Simpson","year":"2007","journal-title":"Thorax"},{"key":"key-10.1136\/thoraxjnl-2014-206067-13","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3109\/10715760903362576","article-title":"Potentially pathogenic bacteria cultured from the sputum of stable asthmatics are associated with increased 8-isoprostane and airway neutrophilia","volume":"44","author":"Wood","year":"2010","journal-title":"Free Radic Res"},{"key":"key-10.1136\/thoraxjnl-2014-206067-14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1183\/09031936.00042208","article-title":"Long-term macrolide therapy in chronic inflammatory airway diseases","volume":"33","author":"Crosbie","year":"2009","journal-title":"Eur Respir J"},{"key":"key-10.1136\/thoraxjnl-2014-206067-15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1710-1492-4-3-111","article-title":"Atypical bacteria and macrolides in asthma","volume":"4","author":"Xepapadaki","year":"2008","journal-title":"Allergy Asthma Clin Immunol"},{"key":"key-10.1136\/thoraxjnl-2014-206067-16","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S1081-1206(10)62409-X","article-title":"Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma","volume":"84","author":"Amayasu","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"key-10.1136\/thoraxjnl-2014-206067-17","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1081-1206(10)62264-8","article-title":"Clarithromycin potentiates glucocorticoid responsiveness in patients with asthma: results of a pilot study","volume":"87","author":"Spahn","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"key-10.1136\/thoraxjnl-2014-206067-18","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/thoraxjnl-2011-200160","article-title":"Combined Haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthma","volume":"67","author":"Essilfie","year":"2012","journal-title":"Thorax"},{"key":"key-10.1136\/thoraxjnl-2014-206067-19","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.4049\/jimmunol.0902287","article-title":"Chlamydial respiratory infection during allergen sensitisation drives neutrophilic allergic airways disease","volume":"184","author":"Horvat","year":"2010","journal-title":"J Immunol"},{"key":"key-10.1136\/thoraxjnl-2014-206067-20","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jaci.2009.10.018","article-title":"Early-life chlamydial lung infection enhances allergic airways disease through age-dependent differences in immunopathology","volume":"125","author":"Horvat","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"key-10.1136\/thoraxjnl-2014-206067-21","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jaci.2012.11.053","article-title":"A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis","volume":"131","author":"Beckett","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"key-10.1136\/thoraxjnl-2014-206067-22","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/mi.2012.99","article-title":"Constitutive production of IL-13 promotes early-life Chlamydia respiratory infection and allergic airway disease","volume":"6","author":"Starkey","year":"2013","journal-title":"Mucosal Immunol"},{"key":"key-10.1136\/thoraxjnl-2014-206067-23","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1126\/science.1233321","article-title":"Interferon-\u03b5 protects the female reproductive tract from viral and bacterial Infection","volume":"339","author":"Fung","year":"2013","journal-title":"Science"},{"key":"key-10.1136\/thoraxjnl-2014-206067-24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1517\/13543784.2013.732997","article-title":"Th2 cytokine antagonists: potential treatments for severe asthma","volume":"22","author":"Hansbro","year":"2012","journal-title":"Expert Opin Investig Drugs"},{"key":"key-10.1136\/thoraxjnl-2014-206067-25","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/thx.2007.090027","article-title":"Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma","volume":"63","author":"Bhavsar","year":"2008","journal-title":"Thorax"},{"key":"key-10.1136\/thoraxjnl-2014-206067-26","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1440-1843.2012.02186.x","article-title":"Macrolides for macrophages in chronic obstructive pulmonary disease","volume":"17","author":"Hansbro","year":"2012","journal-title":"Respirology"},{"key":"key-10.1136\/thoraxjnl-2014-206067-27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1084\/jem.181.1.33","article-title":"Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma","volume":"181","author":"Leung","year":"1995","journal-title":"J Exp Med"},{"key":"key-10.1136\/thoraxjnl-2014-206067-28","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1189\/jlb.0711357","article-title":"Emerging roles of pulmonary macrophages in driving the development of severe asthma","volume":"91","author":"Yang","year":"2012","journal-title":"J Leukoc Biol"},{"key":"key-10.1136\/thoraxjnl-2014-206067-29","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1164\/ajrccm.164.4.2011040","article-title":"Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae","volume":"164","author":"Black","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.1136\/thoraxjnl-2014-206067-30","article-title":"Efficacy of clarithrmycin for the treatment of acute episodes of bronchospasm in children with a history of recurrent wheezing","author":"Eposito","year":"2004"},{"key":"key-10.1136\/thoraxjnl-2014-206067-31","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1378\/chest.121.6.1782","article-title":"Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin","volume":"121","author":"Kraft","year":"2002","journal-title":"CHEST J"},{"key":"key-10.1136\/thoraxjnl-2014-206067-32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1476-5381.2011.01219.x","article-title":"Cytokine\/anti-cytokine therapy\u2014novel treatments for asthma?","volume":"163","author":"Hansbro","year":"2011","journal-title":"Br J Pharmacol"},{"key":"key-10.1136\/thoraxjnl-2014-206067-33","doi-asserted-by":"crossref","first-page":"e1001339","DOI":"10.1371\/journal.ppat.1001339","article-title":"Interleukin-13 promotes susceptibility to Chlamydial infection of the respiratory and genital tracts","volume":"7","author":"Asquith","year":"2011","journal-title":"PLoS Pathog"},{"key":"key-10.1136\/thoraxjnl-2014-206067-34","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/mi.2014.8","article-title":"The complex relationship between inflammation and lung function in severe asthma","volume":"7","author":"Manni","year":"2014","journal-title":"Mucosal Immunol"},{"key":"key-10.1136\/thoraxjnl-2014-206067-35","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa050580","article-title":"Evidence of a role of tumor necrosis factor-\u03b1 in refractory asthma","volume":"354","author":"Berry","year":"2006","journal-title":"N Engl J Med"},{"key":"key-10.1136\/thoraxjnl-2014-206067-36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2174\/187221310793564218","article-title":"TNF-alpha antagonism in severe asthma?","volume":"4","author":"Desai","year":"2010","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"key-10.1136\/thoraxjnl-2014-206067-37","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1164\/rccm.200707-1134OC","article-title":"Clarithromycin targets neutrophilic airway inflammation in refractory asthma","volume":"177","author":"Simpson","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.1136\/thoraxjnl-2014-206067-38","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1128\/CMR.00078-09","article-title":"Mechanisms of action and clinical application of macrolides as immunomodulatory medications","volume":"23","author":"Kanoh","year":"2010","journal-title":"Clin Microbiol Rev"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thoraxjnl-2014-206067","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T05:46:48Z","timestamp":1601099208000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thoraxjnl-2014-206067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,6]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,4,13]]},"published-print":{"date-parts":[[2015,5]]}},"alternative-id":["10.1136\/thoraxjnl-2014-206067"],"URL":"https:\/\/doi.org\/10.1136\/thoraxjnl-2014-206067","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,6]]}}}